Disclosures: Raghav Bassi: Nothing to Disclose, Zubair Bodla: Nothing to Disclose, Mariam Hashmi: Nothing to Disclose, Fatima Niaz: Nothing to Disclose, Muhammad Khalil: Nothing to Disclose, Yaseen Perbtani: Nothing to Disclose, Tony Brar: Nothing to Disclose 1676 ACTIVITY METRICS MEASURED BY WEARABLE TECHNOLOGY CORRELATES WITH PATIENT-REPORTED WELLBEING IN CIRRHOSIS Brian McSteen 1 Jessica Siguencia 1 Russell Rosenblatt 2 Arun Jesudian 2 Ana Krieger 2 Avesh Thuluvath 3 Robert Schwartz 4 Robert Brown 2 Adam Buckholz 5 , 1 NewYork-Presbyterian, Weill Cornell Campus, 2 Weill Cornell Medicine, 3 Northwestern University Feinberg School of Medicine, 4 Weill Cornell Medical College, 5 New York Presbyterian Hospital Program Background: Inactivity is associated with progressive sarcopenia, worse transplant outcomes and increased mortality in cirrhosis
It works on two hormonal pathways instead of one, which clinical trials have shown can produce greater weight loss compared to semaglutide alone
PMID: 3514343
Among the microorganisms altered by liraglutide, Lactobacillus delbrueckii was the most significantly increased species
Results: The total number of CRC cases in the whole population was 1014970 and a total of 3105 cases of CRC were found in 151105 cases of PLA
The dosing is gradually titrated upward over several weeks to minimize gastrointestinal side effects
